About-cancer/treatment/drugs/defibrotide-sodium/zh

去纖蛋白鈉

該頁面包含有關去纖蛋白鈉的簡要信息，以及一些鏈接，這些鏈接指向有關該藥物的使用，研究結果和正在進行的臨床試驗的更多信息。

美國品牌名稱

Defitelio

FDA 批准

是

該藥物的FDA標籤信息可從DailyMed獲得。

用於癌症

去纖蛋白鈉被批准用於治療：

• 肝靜脈閉塞性疾病 成人和兒童（也稱為正弦竇阻塞綜合徵）在接受幹細胞移植後也有腎臟或肺部疾病。

更多關於去纖蛋白鈉

NCI藥物詞典中的定義-該藥物的詳細科學定義和其他名稱。

MedlinePlus有關去纖蛋白鈉的信息-有關該藥物重要信息的俗語摘要，可能包括以下內容：

• 關於這種藥物的警告，

• 這種藥物的用途和用法，

• 在使用這種藥物之前，您應該告訴醫生什麼，

• what you should know about this drug before using it,

• other drugs that may interact with this drug, and

• possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Clinical Trials Accepting Patients

Find Clinical Trials for Defibrotide Sodium - Check for trials from NCI's list of cancer clinical trials now accepting patients.

Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.